Interim Operational Management
With its executive level team and medical advisory board, MedNest provides operational experience to help you transition from a virtual company to a fully staffed operation in the US.
These services could include:
|
|
|
Executive Interim Management
- US Executive presentce / interim CEO roles
- Interim Clinical Leadership / CMO roles (ex: clinical trials supervision)
- Sales Force coaching and development, business operations
- On-demand Lead Generation campaings
|
|
|
Corporate Identity Creation (with select Partners)
- Selection, formation and operating agreement of US legal Structure
- Virtual offices, incubator or full office selection
- Comprehensive Accounting Management Services
- Collateral creation, web presence and Industry Associations enrollment
|
|
|
Local Team Build-up
- Organizational structure definition, job descriptions, objectives
- Sales Force deployment and compensation plans
- Payroll and Benefits (with Partners)
- Executive Search and pre-selection (sometimes with Partners)
|
And, as your US Management team, here are a few examples of what we could do:
Recruit a Medical Advisory Board, and later facilitate its work, to guide your clinical research and support your clinical value proposition
Establish a regulatory (FDA/Customs) roadmap and predicates search, leading to a FDA 510k submission (pre-Market approval)
Study the Market opportunities and related reimbursement fees, to define the most relevant target markets segments and related sales channels
Carry and present your value proposition to major healthcare players (i.e.: Pharma, CROs, Hospitals) to secure your "first" deal "in country"
Manage and operate your first clinical or commercial partnerships
Search, qualify and position your company to relevant commercial partners/distributors, relevant to the specialized niche markets that you are targeting
Search and help you apply for specialized US grants (i.e.: NHI, NJ Edison Fund, DoD, Professional Associations) that could fund clinical or commercial projects
Working closely with you to raise US funds, including upgrading your business plan and preparing you in presenting to the specialized VCs in the US
Resulting in
-
The reduction of your "time to market" timeline
-
Smarter and phased FDA submission strategies, allowing faster and phased market access
-
Value driven pricing, maximizing the potential of your technology within the US Healthcare System
-
Reduction of operational risk of your initial US footprint : a team is stronger than a single player alone
-
Grounded growth plans that increase your credibility (and success rates) when raising funds
-
First "in country" revenues, which by diversifying your revenue streams, reduce your operational risks
-
Increase your company valuation by Identifying new applications and markets for your technology
|
|
